Company News for Jun 2, 2021

Zacks Equity Research Published on June 02, 2021

Abbott Laboratories (ABT - Free Report) shares plunged 9.3% after the company reduced its 2021 adjusted earnings per share forecast to the range of $4.30 to $4.50 from $5 projected earlier.
Cloudera, Inc.'s shares soared 23.9% after disclosing the deal to be acquired by Clayton, Dubilier & Rice LLC and KKR & Co. Inc. (KKR - Free Report) .
Shares of Canopy Growth Corp. (CGC - Free Report) plummeted 6.9% after reporting fourth-quarter fiscal 2021 adjusted loss per share of $0.66, wider-than the Zacks Consensus Estimate of $0.18.
Shares of NIO Inc. (NIO - Free Report) climbed 9.6% after the company announced that the delivery of its electric vehicle jumped 95% year over year to 6,711 units in May.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.